Biotech Vet Laland, Four Others, Join WeissComm
Charting the future of public relations
Holmes Report
CEO

Biotech Vet Laland, Four Others, Join WeissComm

WeissComm Partners, a leading independent healthcare public relations specialist, has added several new staff, including Paul Laland, who has joined as executive vice president from Novacea, where he was vice president of corporate communications.

Paul Holmes

NEW YORK—WeissComm Partners, a leading independent healthcare public relations specialist, has added several new staff, including Paul Laland, who has joined as executive vice president from Novacea, where he was vice president of corporate communications.

 

Laland brings nearly 25 years of experience in international biotechnology and pharmaceutical corporate and product communications. In addition to holding corporate communications positions at VaxGen, Genentech, G.D. Searle and Deltagen, Laland served as senior partner and co-chair of the global Healthcare Practice at Fleishman-Hillard, where he established and led the Life Sciences Group on the West Coast. He will report to Diane Weiser, president and chief operating officer. 

 

Additional hires include four senior associates: Mark Bennett, who joins from Bayer HealthCare Pharmaceuticals, where he was senior manager, corporate communications; Emily Poe, formerly of Vox Medica; Scott Santiamo, formerly a communications consultant at MedImmune; and Jessica Volchok, who joins from FischerHealth, a Porter Novelli company. 

 

The firm has also added several new clients including Celladon Corporation, DNA Direct, Fisher BioPharma Services, GTx. Inc., Isis Pharmaceuticals, and Topaz Pharmaceuticals.

View Style:

Load 3 More
comments powered by Disqus